Find Related Trials for The Following Conditions

General Information

NicoDerm CQ has been approved as an OTC stop smoking aid.
NicoDerm CQ is the first OTC nicotine patch to be available in all
prescription strengths: 21 mg, 14 mg, and 7 mg per day. NicoDerm CQ
provides a step down program that allows smokers to gradually
reduce their nicotine intake, rather than stop abruptly. Most
smokers should start with Step 1 (21 mg) for six weeks; step down
to Step 2 (14 mg) for two weeks; and then use Step 3 (7 mg) for two
weeks.

NicoDerm CQ is the only nicotine patch approved for light
smokers. Those who smoke 10 or fewer cigarettes a day should start
with the Step 2 (14 mg) dose for six weeks and then step down to
the Step 3 (7 mg) dose for two weeks.

NicoDerm CQ is the only patch that can be worn for either 16 or
24 hours. Smokers who crave cigarettes when they wake up can wear
the patch for 24 hours.

Certain patient populations should seek the advice of a health
professional prior to starting therapy with nicotine patches. These
include people under the age of 18; people with heart disease, an
irregular heart beat, or those who have had a recent heart attack;
people with high blood pressure not controlled with medication;
people taking prescription medicine for depression or asthma; or
people with skin problems or those who are allergic to adhesive
tape. Pregnant or nursing women should first try to stop smoking
without the nicotine patch and seek the advice of a health
professional before using a nicotine patch.

Side Effects

The most frequently reported adverse effects associated with
nicotine patches are usually mild and include itching or burning at
the site of application and dizziness.